This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Botnick, L. E. Articles by Hellman, S. Search for Related Content PubMed PubMed Citation Articles by Botnick, L. E. Articles by Hellman, S.

Differential Effects of Cytotoxic Agents on Hematopoietic Progenitors¹

Joint Center for Radiation Therapy, Department of Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02115

In order to predict the effect of chemotherapeutic agents on the hematopoietic progenitor compartment, it is necessary to have a hypothesis concerning the dynamics of the cells within the compartment. By viewing this compartment as a continuum of cells with varying self-renewal capacity, one can assess the significance of the stem cell damage incurred following a single drug dose. Vinblastine, 5-fluorouracil, cyclophosphamide, busulfan, and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) were investigated. The acute toxicity of the drug-exposed marrow was studied by the colony-forming units-spleen (CFU-S) and agar diffusion chamber assay. Busulfan and BCNU were found to kill CFU-S preferentially. By following CFU-S recovery for 14 days post drug, different recovery patterns are noted. Busulfan and BCNU produce prolonged depression in CFU-S, whereas cyclophosphamide and 5-fluorouracil show relatively rapid recovery. If one determines the R_s (a measure of proliferative capacity) after drug, busulfan and, to a lesser extent, BCNU produce a prolonged depression without return to normal even 650 days post drug. No such depression is noted with the other drugs. The data from the recovery curves and R_s support the notion of stem cells being heterogeneous with regard to self-renewal capacity. The agar diffusion chamber and CFU-S acute survival curves would not have predicted which drugs cause significant proliferative damage. Only with the use of CFU-S recovery and ratio of CFU-S can prolonged marrow damage be ascertained.

¹ Study supported in part by USPHS Grants CA-12662, CA-10941, and CA-09078.

² To whom requests for reprints should be addressed, at Shields Warren Research Laboratories, 50 Binney Street, Boston, Mass. 02115.

Received 9/ 2/80. Accepted 2/25/81.

This article has been cited by other articles:

				B. Metzler, P. Gfeller, G. Wieczorek, J. Li, B. Nuesslein-Hildesheim, A. Katopodis, M. Mueller, and V. Brinkmann Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure Int. Immunol., May 1, 2008; 20(5): 633 - 644. [Abstract] [Full Text] [PDF]

				G. Mostoslavsky, A. J. Fabian, S. Rooney, F. W. Alt, and R. C. Mulligan Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer PNAS, October 31, 2006; 103(44): 16406 - 16411. [Abstract] [Full Text] [PDF]

				K. Kuramoto, D. Follman, P. Hematti, S. Sellers, M. O. Laukkanen, R. Seggewiss, M. E. Metzger, A. Krouse, R. E. Donahue, C. von Kalle, et al. The impact of low-dose busulfan on clonal dynamics in nonhuman primates Blood, September 1, 2004; 104(5): 1273 - 1280. [Abstract] [Full Text] [PDF]

				K. Kusano, S. Ebara, K. Tachibana, T. Nishimura, S. Sato, T. Kuwaki, and T. Taniyama A potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor Blood, February 1, 2004; 103(3): 836 - 842. [Abstract] [Full Text] [PDF]

				C. Buschfort-Papewalis, T. Moritz, B. Liedert, and J. Thomale Down-regulation of DNA repair in human CD34+ progenitor cells corresponds to increased drug sensitivity and apoptotic response Blood, July 18, 2002; 100(3): 845 - 853. [Abstract] [Full Text] [PDF]

				M. Venturini, G. Lunardi, L. Del Mastro, M. O. Vannozzi, G. Tolino, G. Numico, M. Viale, I. Pastrone, C. Angiolini, G. Bertelli, et al. Sequence Effect of Epirubicin and Paclitaxel Treatment on Pharmacokinetics and Toxicity J. Clin. Oncol., May 10, 2000; 18(10): 2116 - 2125. [Abstract] [Full Text] [PDF]

				R. van Os, S. Robinson, T. Sheridan, and P. M. Mauch Granulocyte-Colony Stimulating Factor Impedes Recovery from Damage Caused by Cytotoxic Agents through Increased Differentiation at the Expense of Self-Renewal Stem Cells, March 1, 2000; 18(2): 120 - 127. [Abstract] [Full Text]

				R. van Os, S. Robinson, T. Sheridan, J. M.K. Mislow, D. Dawes, and P. M. Mauch Granulocyte Colony-Stimulating Factor Enhances Bone Marrow Stem Cell Damage Caused by Repeated Administration of Cytotoxic Agents Blood, September 15, 1998; 92(6): 1950 - 1956. [Abstract] [Full Text] [PDF]

				R. S. Basch, F. L. Quito, J. Beh, and J. A. Hirst Growth of Human Hematopoietic Cells in Immunodeficient Mice Conditioned with Cyclophosphamide and Busulfan Stem Cells, July 1, 1997; 15(4): 314 - 323. [Abstract] [Full Text]